Energy News / Shareholders Foundation, Inc.

NYSE:AGN Shareholder Notice: Lawsuit Alleges Securities Laws Violations by Allergan Plc

Via: ReleaseWire

Updated 10:09 AM CST, Fri, February 01,2019

A lawsuit was filed on behalf of investors in Allergan plc (NYSE:AGN) shares over alleged securities laws violations.

San Diego, CA -- (SBWIRE) -- 02/01/2019 -- An investor, who purchased shares of Allergan plc (NYSE: AGN), filed a lawsuit over alleged Securities Laws violations by Allergan plc in connection with certain allegedly false and misleading statements.

Investors who purchased shares of Allergan plc (NYSE: AGN) have certain options and for certain investors are short and strict deadlines running. Deadline: February 19, 2019. NYSE: AGN investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

Dublin, Ireland based Allergan plc, a pharmaceutical company, develops, manufactures, and commercializes branded pharmaceutical, device, biologic, surgical, and regenerative medicine products worldwide. On December 18, 2018, France's National Agency for the Safety of Medicines & Health Products ordered the recall of textured breast implants manufactured by Allergan plc from the European market, stating that the implants "have been linked to a rare form of cancer"—specifically, anaplastic large cell lymphoma. On December 19, 2018, Allergan plc stated that it would remove its textured breast implants from the European market.

The plaintiff alleges on behalf of purchasers of Allergan plc (NYSE: AGN) common shares between May 9, 2017, and December 19, 2018, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between May 9, 2017, and December 19, 2018, the Allergan concealed from investors the fact that the Company's CE Mark for its textured breast implants and tissue expanders was expiring in Europe.

Those who purchased shares of Allergan plc (NYSE: AGN) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

For more information on this press release visit:
http://www.sbwire.com/press-releases/nyseagn-shareholder-notice-lawsuit-alleges-securities-laws-violations-by-allergan-plc-1138402.htm

Media Relations Contact
Michael Daniels
858-779-1554
Email: Click to Email Michael Daniels
Web: http://www.ShareholdersFoundation.com